This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Jump to section
Related Articles
Cited By...
- Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines
- Treatment of refractory thyroid cancer
- Clinical outcomes of a cohort of patients with central nervous system metastases from thyroid cancer
- Pulmonary metastases in differentiated thyroid cancer: efficacy of radioiodine therapy and prognostic factors
- Rare metastases of differentiated thyroid carcinoma: pictorial review
- Delayed Initial Radioactive Iodine Therapy Resulted in Poor Survival in Patients with Metastatic Differentiated Thyroid Carcinoma: A Retrospective Statistical Analysis of 198 Cases
- Thyroid Carcinoma
- Standard and Emerging Therapies for Metastatic Differentiated Thyroid Cancer
- Bone Metastases of Differentiated Thyroid Cancer: The Importance of Early Diagnosis and 131I Therapy on Prognosis
- Bone metastases from differentiated thyroid carcinoma
- Bone metastases of differentiated thyroid cancer: impact of early 131I-based detection on outcome
- Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review
- The Evolving Role of 131I for the Treatment of Differentiated Thyroid Carcinoma
- Recombinant TSH-Stimulated, Radioguided Differentiated Thyroid Carcinoma Surgery